nodes	percent_of_prediction	percent_of_DWPC	metapath
Flurazepam—SLC22A2—Cytarabine—lymphatic system cancer	0.334	0.444	CbGbCtD
Flurazepam—CYP2E1—Mitoxantrone—lymphatic system cancer	0.121	0.161	CbGbCtD
Flurazepam—ABCB1—Mitoxantrone—lymphatic system cancer	0.0613	0.0815	CbGbCtD
Flurazepam—CYP3A4—Cytarabine—lymphatic system cancer	0.0533	0.0709	CbGbCtD
Flurazepam—CYP3A4—Teniposide—lymphatic system cancer	0.0525	0.0698	CbGbCtD
Flurazepam—ABCB1—Vincristine—lymphatic system cancer	0.0422	0.0561	CbGbCtD
Flurazepam—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0367	0.0488	CbGbCtD
Flurazepam—ABCB1—Methotrexate—lymphatic system cancer	0.0255	0.0339	CbGbCtD
Flurazepam—CYP3A4—Vincristine—lymphatic system cancer	0.0253	0.0336	CbGbCtD
Flurazepam—Coma—Fludarabine—lymphatic system cancer	0.00457	0.0185	CcSEcCtD
Flurazepam—Agranulocytosis—Mechlorethamine—lymphatic system cancer	0.00403	0.0163	CcSEcCtD
Flurazepam—Thinking abnormal—Carmustine—lymphatic system cancer	0.0035	0.0141	CcSEcCtD
Flurazepam—Gait disturbance—Carmustine—lymphatic system cancer	0.00328	0.0132	CcSEcCtD
Flurazepam—Gait disturbance—Vincristine—lymphatic system cancer	0.00313	0.0126	CcSEcCtD
Flurazepam—Sweating—Teniposide—lymphatic system cancer	0.00305	0.0123	CcSEcCtD
Flurazepam—Leukopenia—Mechlorethamine—lymphatic system cancer	0.00302	0.0122	CcSEcCtD
Flurazepam—Disorientation—Bleomycin—lymphatic system cancer	0.00297	0.012	CcSEcCtD
Flurazepam—Coma—Carmustine—lymphatic system cancer	0.00292	0.0118	CcSEcCtD
Flurazepam—Coma—Vincristine—lymphatic system cancer	0.00279	0.0113	CcSEcCtD
Flurazepam—Mental disability—Carmustine—lymphatic system cancer	0.00278	0.0112	CcSEcCtD
Flurazepam—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.00275	0.0111	CcSEcCtD
Flurazepam—Flushing—Teniposide—lymphatic system cancer	0.00265	0.0107	CcSEcCtD
Flurazepam—Anorexia—Mechlorethamine—lymphatic system cancer	0.00262	0.0106	CcSEcCtD
Flurazepam—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00239	0.00967	CcSEcCtD
Flurazepam—Agitation—Teniposide—lymphatic system cancer	0.00229	0.00924	CcSEcCtD
Flurazepam—Anaphylactoid reaction—Mitoxantrone—lymphatic system cancer	0.00223	0.00902	CcSEcCtD
Flurazepam—Leukopenia—Teniposide—lymphatic system cancer	0.00223	0.009	CcSEcCtD
Flurazepam—Ataxia—Carmustine—lymphatic system cancer	0.00218	0.00883	CcSEcCtD
Flurazepam—Chest pain—Teniposide—lymphatic system cancer	0.00212	0.00856	CcSEcCtD
Flurazepam—Ataxia—Vincristine—lymphatic system cancer	0.00209	0.00843	CcSEcCtD
Flurazepam—Confusional state—Teniposide—lymphatic system cancer	0.00205	0.00827	CcSEcCtD
Flurazepam—Agitation—Fludarabine—lymphatic system cancer	0.00201	0.00812	CcSEcCtD
Flurazepam—Aspartate aminotransferase increased—Vincristine—lymphatic system cancer	0.002	0.00807	CcSEcCtD
Flurazepam—Hyperhidrosis—Teniposide—lymphatic system cancer	0.00196	0.00793	CcSEcCtD
Flurazepam—Leukopenia—Fludarabine—lymphatic system cancer	0.00196	0.00791	CcSEcCtD
Flurazepam—Pruritus—Mechlorethamine—lymphatic system cancer	0.00195	0.00787	CcSEcCtD
Flurazepam—Aspartate aminotransferase increased—Mitoxantrone—lymphatic system cancer	0.00194	0.00786	CcSEcCtD
Flurazepam—Anorexia—Teniposide—lymphatic system cancer	0.00193	0.00782	CcSEcCtD
Flurazepam—Hypotension—Teniposide—lymphatic system cancer	0.0019	0.00766	CcSEcCtD
Flurazepam—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00188	0.00761	CcSEcCtD
Flurazepam—Arthralgia—Fludarabine—lymphatic system cancer	0.00186	0.00752	CcSEcCtD
Flurazepam—Dyspnoea—Teniposide—lymphatic system cancer	0.00181	0.00731	CcSEcCtD
Flurazepam—Confusional state—Fludarabine—lymphatic system cancer	0.0018	0.00727	CcSEcCtD
Flurazepam—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00178	0.00721	CcSEcCtD
Flurazepam—Decreased appetite—Teniposide—lymphatic system cancer	0.00176	0.00713	CcSEcCtD
Flurazepam—Vomiting—Mechlorethamine—lymphatic system cancer	0.00175	0.00707	CcSEcCtD
Flurazepam—Rash—Mechlorethamine—lymphatic system cancer	0.00174	0.00702	CcSEcCtD
Flurazepam—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00173	0.00701	CcSEcCtD
Flurazepam—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00172	0.00697	CcSEcCtD
Flurazepam—Flushing—Bleomycin—lymphatic system cancer	0.00171	0.0069	CcSEcCtD
Flurazepam—Anorexia—Fludarabine—lymphatic system cancer	0.0017	0.00687	CcSEcCtD
Flurazepam—Feeling abnormal—Teniposide—lymphatic system cancer	0.00167	0.00676	CcSEcCtD
Flurazepam—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00166	0.00673	CcSEcCtD
Flurazepam—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00166	0.00671	CcSEcCtD
Flurazepam—Sweating—Vincristine—lymphatic system cancer	0.00164	0.00662	CcSEcCtD
Flurazepam—Nausea—Mechlorethamine—lymphatic system cancer	0.00164	0.00661	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00163	0.00657	CcSEcCtD
Flurazepam—Hallucination—Carmustine—lymphatic system cancer	0.0016	0.00646	CcSEcCtD
Flurazepam—Sweating—Mitoxantrone—lymphatic system cancer	0.0016	0.00645	CcSEcCtD
Flurazepam—Dyspnoea—Fludarabine—lymphatic system cancer	0.00159	0.00643	CcSEcCtD
Flurazepam—Dyspepsia—Fludarabine—lymphatic system cancer	0.00157	0.00635	CcSEcCtD
Flurazepam—Dysarthria—Methotrexate—lymphatic system cancer	0.00157	0.00633	CcSEcCtD
Flurazepam—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00155	0.00628	CcSEcCtD
Flurazepam—Decreased appetite—Fludarabine—lymphatic system cancer	0.00155	0.00627	CcSEcCtD
Flurazepam—Hallucination—Vincristine—lymphatic system cancer	0.00153	0.00617	CcSEcCtD
Flurazepam—Constipation—Fludarabine—lymphatic system cancer	0.00153	0.00616	CcSEcCtD
Flurazepam—Flushing—Carmustine—lymphatic system cancer	0.00149	0.00603	CcSEcCtD
Flurazepam—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00147	0.00594	CcSEcCtD
Flurazepam—Asthenia—Teniposide—lymphatic system cancer	0.00146	0.00589	CcSEcCtD
Flurazepam—Pruritus—Teniposide—lymphatic system cancer	0.00144	0.0058	CcSEcCtD
Flurazepam—Leukopenia—Bleomycin—lymphatic system cancer	0.00143	0.0058	CcSEcCtD
Flurazepam—Diarrhoea—Teniposide—lymphatic system cancer	0.00139	0.00561	CcSEcCtD
Flurazepam—Chest pain—Bleomycin—lymphatic system cancer	0.00136	0.00551	CcSEcCtD
Flurazepam—Coma—Methotrexate—lymphatic system cancer	0.00135	0.00547	CcSEcCtD
Flurazepam—Confusional state—Bleomycin—lymphatic system cancer	0.00132	0.00533	CcSEcCtD
Flurazepam—Vision blurred—Carmustine—lymphatic system cancer	0.00132	0.00533	CcSEcCtD
Flurazepam—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00131	0.00529	CcSEcCtD
Flurazepam—Vomiting—Teniposide—lymphatic system cancer	0.00129	0.00522	CcSEcCtD
Flurazepam—Agitation—Carmustine—lymphatic system cancer	0.00129	0.0052	CcSEcCtD
Flurazepam—Asthenia—Fludarabine—lymphatic system cancer	0.00128	0.00517	CcSEcCtD
Flurazepam—Rash—Teniposide—lymphatic system cancer	0.00128	0.00517	CcSEcCtD
Flurazepam—Dermatitis—Teniposide—lymphatic system cancer	0.00128	0.00517	CcSEcCtD
Flurazepam—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00127	0.00515	CcSEcCtD
Flurazepam—Headache—Teniposide—lymphatic system cancer	0.00127	0.00514	CcSEcCtD
Flurazepam—Pruritus—Fludarabine—lymphatic system cancer	0.00126	0.0051	CcSEcCtD
Flurazepam—Leukopenia—Carmustine—lymphatic system cancer	0.00125	0.00506	CcSEcCtD
Flurazepam—Anorexia—Bleomycin—lymphatic system cancer	0.00125	0.00504	CcSEcCtD
Flurazepam—Agitation—Vincristine—lymphatic system cancer	0.00123	0.00496	CcSEcCtD
Flurazepam—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00123	0.00495	CcSEcCtD
Flurazepam—Hypotension—Bleomycin—lymphatic system cancer	0.00122	0.00494	CcSEcCtD
Flurazepam—Diarrhoea—Fludarabine—lymphatic system cancer	0.00122	0.00493	CcSEcCtD
Flurazepam—Nausea—Teniposide—lymphatic system cancer	0.00121	0.00487	CcSEcCtD
Flurazepam—Leukopenia—Vincristine—lymphatic system cancer	0.0012	0.00483	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00119	0.00482	CcSEcCtD
Flurazepam—Chest pain—Carmustine—lymphatic system cancer	0.00119	0.00481	CcSEcCtD
Flurazepam—Anxiety—Carmustine—lymphatic system cancer	0.00119	0.0048	CcSEcCtD
Flurazepam—Dyspnoea—Bleomycin—lymphatic system cancer	0.00117	0.00471	CcSEcCtD
Flurazepam—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00116	0.0047	CcSEcCtD
Flurazepam—Confusional state—Carmustine—lymphatic system cancer	0.00115	0.00465	CcSEcCtD
Flurazepam—Decreased appetite—Bleomycin—lymphatic system cancer	0.00114	0.00459	CcSEcCtD
Flurazepam—Vomiting—Fludarabine—lymphatic system cancer	0.00113	0.00458	CcSEcCtD
Flurazepam—Rash—Fludarabine—lymphatic system cancer	0.00112	0.00455	CcSEcCtD
Flurazepam—Dermatitis—Fludarabine—lymphatic system cancer	0.00112	0.00454	CcSEcCtD
Flurazepam—Headache—Fludarabine—lymphatic system cancer	0.00112	0.00452	CcSEcCtD
Flurazepam—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.00111	0.00449	CcSEcCtD
Flurazepam—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00111	0.00447	CcSEcCtD
Flurazepam—Chest pain—Mitoxantrone—lymphatic system cancer	0.00111	0.00447	CcSEcCtD
Flurazepam—Anxiety—Mitoxantrone—lymphatic system cancer	0.0011	0.00446	CcSEcCtD
Flurazepam—Lethargy—Methotrexate—lymphatic system cancer	0.0011	0.00444	CcSEcCtD
Flurazepam—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00109	0.0044	CcSEcCtD
Flurazepam—Anorexia—Carmustine—lymphatic system cancer	0.00109	0.0044	CcSEcCtD
Flurazepam—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00108	0.00436	CcSEcCtD
Flurazepam—Confusional state—Mitoxantrone—lymphatic system cancer	0.00107	0.00432	CcSEcCtD
Flurazepam—Hypotension—Carmustine—lymphatic system cancer	0.00107	0.00431	CcSEcCtD
Flurazepam—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00106	0.00429	CcSEcCtD
Flurazepam—Nausea—Fludarabine—lymphatic system cancer	0.00106	0.00428	CcSEcCtD
Flurazepam—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00105	0.00426	CcSEcCtD
Flurazepam—Shock—Mitoxantrone—lymphatic system cancer	0.00104	0.00422	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00104	0.0042	CcSEcCtD
Flurazepam—Anorexia—Vincristine—lymphatic system cancer	0.00104	0.0042	CcSEcCtD
Flurazepam—Irritability—Methotrexate—lymphatic system cancer	0.00103	0.00415	CcSEcCtD
Flurazepam—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00103	0.00415	CcSEcCtD
Flurazepam—Hypotension—Vincristine—lymphatic system cancer	0.00102	0.00412	CcSEcCtD
Flurazepam—Dyspnoea—Carmustine—lymphatic system cancer	0.00102	0.00411	CcSEcCtD
Flurazepam—Somnolence—Carmustine—lymphatic system cancer	0.00101	0.0041	CcSEcCtD
Flurazepam—Anorexia—Mitoxantrone—lymphatic system cancer	0.00101	0.00409	CcSEcCtD
Flurazepam—Ataxia—Methotrexate—lymphatic system cancer	0.00101	0.00409	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000993	0.00401	CcSEcCtD
Flurazepam—Decreased appetite—Carmustine—lymphatic system cancer	0.000992	0.00401	CcSEcCtD
Flurazepam—Hypotension—Mitoxantrone—lymphatic system cancer	0.000992	0.00401	CcSEcCtD
Flurazepam—Constipation—Carmustine—lymphatic system cancer	0.000976	0.00395	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000967	0.00391	CcSEcCtD
Flurazepam—Decreased appetite—Vincristine—lymphatic system cancer	0.000947	0.00383	CcSEcCtD
Flurazepam—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000946	0.00382	CcSEcCtD
Flurazepam—Somnolence—Mitoxantrone—lymphatic system cancer	0.000944	0.00381	CcSEcCtD
Flurazepam—Feeling abnormal—Carmustine—lymphatic system cancer	0.000941	0.0038	CcSEcCtD
Flurazepam—Asthenia—Bleomycin—lymphatic system cancer	0.000938	0.00379	CcSEcCtD
Flurazepam—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000934	0.00378	CcSEcCtD
Flurazepam—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000934	0.00377	CcSEcCtD
Flurazepam—Constipation—Vincristine—lymphatic system cancer	0.000932	0.00377	CcSEcCtD
Flurazepam—Pruritus—Bleomycin—lymphatic system cancer	0.000925	0.00374	CcSEcCtD
Flurazepam—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000923	0.00373	CcSEcCtD
Flurazepam—Constipation—Mitoxantrone—lymphatic system cancer	0.000908	0.00367	CcSEcCtD
Flurazepam—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.000892	0.0036	CcSEcCtD
Flurazepam—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000891	0.0036	CcSEcCtD
Flurazepam—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000875	0.00353	CcSEcCtD
Flurazepam—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000868	0.00351	CcSEcCtD
Flurazepam—Vomiting—Bleomycin—lymphatic system cancer	0.000832	0.00336	CcSEcCtD
Flurazepam—Drowsiness—Methotrexate—lymphatic system cancer	0.000829	0.00335	CcSEcCtD
Flurazepam—Rash—Bleomycin—lymphatic system cancer	0.000825	0.00333	CcSEcCtD
Flurazepam—Dermatitis—Bleomycin—lymphatic system cancer	0.000824	0.00333	CcSEcCtD
Flurazepam—Asthenia—Carmustine—lymphatic system cancer	0.000819	0.00331	CcSEcCtD
Flurazepam—Sweating—Methotrexate—lymphatic system cancer	0.000795	0.00321	CcSEcCtD
Flurazepam—Asthenia—Vincristine—lymphatic system cancer	0.000782	0.00316	CcSEcCtD
Flurazepam—Diarrhoea—Carmustine—lymphatic system cancer	0.000781	0.00316	CcSEcCtD
Flurazepam—Nausea—Bleomycin—lymphatic system cancer	0.000777	0.00314	CcSEcCtD
Flurazepam—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000774	0.00313	CcSEcCtD
Flurazepam—Asthenia—Mitoxantrone—lymphatic system cancer	0.000762	0.00308	CcSEcCtD
Flurazepam—Dizziness—Carmustine—lymphatic system cancer	0.000755	0.00305	CcSEcCtD
Flurazepam—Diarrhoea—Vincristine—lymphatic system cancer	0.000746	0.00301	CcSEcCtD
Flurazepam—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000726	0.00293	CcSEcCtD
Flurazepam—Vomiting—Carmustine—lymphatic system cancer	0.000726	0.00293	CcSEcCtD
Flurazepam—Dizziness—Vincristine—lymphatic system cancer	0.000721	0.00291	CcSEcCtD
Flurazepam—Rash—Carmustine—lymphatic system cancer	0.00072	0.00291	CcSEcCtD
Flurazepam—Dermatitis—Carmustine—lymphatic system cancer	0.000719	0.00291	CcSEcCtD
Flurazepam—Headache—Carmustine—lymphatic system cancer	0.000715	0.00289	CcSEcCtD
Flurazepam—Vomiting—Vincristine—lymphatic system cancer	0.000693	0.0028	CcSEcCtD
Flurazepam—Rash—Vincristine—lymphatic system cancer	0.000687	0.00278	CcSEcCtD
Flurazepam—Dermatitis—Vincristine—lymphatic system cancer	0.000687	0.00277	CcSEcCtD
Flurazepam—Headache—Vincristine—lymphatic system cancer	0.000683	0.00276	CcSEcCtD
Flurazepam—Nausea—Carmustine—lymphatic system cancer	0.000678	0.00274	CcSEcCtD
Flurazepam—Vomiting—Mitoxantrone—lymphatic system cancer	0.000675	0.00273	CcSEcCtD
Flurazepam—Rash—Mitoxantrone—lymphatic system cancer	0.000669	0.0027	CcSEcCtD
Flurazepam—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000669	0.0027	CcSEcCtD
Flurazepam—Headache—Mitoxantrone—lymphatic system cancer	0.000665	0.00269	CcSEcCtD
Flurazepam—Nausea—Vincristine—lymphatic system cancer	0.000647	0.00262	CcSEcCtD
Flurazepam—Dysgeusia—Methotrexate—lymphatic system cancer	0.000635	0.00256	CcSEcCtD
Flurazepam—Nausea—Mitoxantrone—lymphatic system cancer	0.00063	0.00255	CcSEcCtD
Flurazepam—Vision blurred—Methotrexate—lymphatic system cancer	0.000611	0.00247	CcSEcCtD
Flurazepam—Leukopenia—Methotrexate—lymphatic system cancer	0.00058	0.00234	CcSEcCtD
Flurazepam—Arthralgia—Methotrexate—lymphatic system cancer	0.000552	0.00223	CcSEcCtD
Flurazepam—Chest pain—Methotrexate—lymphatic system cancer	0.000552	0.00223	CcSEcCtD
Flurazepam—Confusional state—Methotrexate—lymphatic system cancer	0.000533	0.00215	CcSEcCtD
Flurazepam—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000529	0.00214	CcSEcCtD
Flurazepam—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000511	0.00207	CcSEcCtD
Flurazepam—Anorexia—Methotrexate—lymphatic system cancer	0.000504	0.00204	CcSEcCtD
Flurazepam—Hypotension—Methotrexate—lymphatic system cancer	0.000494	0.002	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000482	0.00195	CcSEcCtD
Flurazepam—Dyspnoea—Methotrexate—lymphatic system cancer	0.000471	0.00191	CcSEcCtD
Flurazepam—Somnolence—Methotrexate—lymphatic system cancer	0.00047	0.0019	CcSEcCtD
Flurazepam—Dyspepsia—Methotrexate—lymphatic system cancer	0.000465	0.00188	CcSEcCtD
Flurazepam—Decreased appetite—Methotrexate—lymphatic system cancer	0.00046	0.00186	CcSEcCtD
Flurazepam—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000436	0.00176	CcSEcCtD
Flurazepam—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000432	0.00175	CcSEcCtD
Flurazepam—Asthenia—Methotrexate—lymphatic system cancer	0.000379	0.00153	CcSEcCtD
Flurazepam—Pruritus—Methotrexate—lymphatic system cancer	0.000374	0.00151	CcSEcCtD
Flurazepam—Diarrhoea—Methotrexate—lymphatic system cancer	0.000362	0.00146	CcSEcCtD
Flurazepam—Dizziness—Methotrexate—lymphatic system cancer	0.00035	0.00141	CcSEcCtD
Flurazepam—Vomiting—Methotrexate—lymphatic system cancer	0.000336	0.00136	CcSEcCtD
Flurazepam—Rash—Methotrexate—lymphatic system cancer	0.000333	0.00135	CcSEcCtD
Flurazepam—Dermatitis—Methotrexate—lymphatic system cancer	0.000333	0.00135	CcSEcCtD
Flurazepam—Headache—Methotrexate—lymphatic system cancer	0.000331	0.00134	CcSEcCtD
Flurazepam—Nausea—Methotrexate—lymphatic system cancer	0.000314	0.00127	CcSEcCtD
